• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism.轻度新冠病毒疾病作为静脉血栓栓塞的一个风险因素。
Cureus. 2021 Sep 24;13(9):e18236. doi: 10.7759/cureus.18236. eCollection 2021 Sep.
2
Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis.接受血栓预防的COVID-19住院患者的静脉血栓栓塞:一项系统评价和荟萃分析
J Clin Med. 2020 Aug 3;9(8):2489. doi: 10.3390/jcm9082489.
3
Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis.2019年冠状病毒病住院患者静脉血栓栓塞的发生率:一项系统评价和荟萃分析
Front Cardiovasc Med. 2020 Aug 6;7:151. doi: 10.3389/fcvm.2020.00151. eCollection 2020.
4
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.COVID-19 患者接受抗栓治疗时的静脉血栓栓塞症的系统评估:发生率和 D-二聚体作为预测因素的作用。
J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z.
5
COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.危重症患者感染新型冠状病毒肺炎后发生静脉血栓栓塞的风险很高。
Eur J Vasc Endovasc Surg. 2021 Apr;61(4):628-634. doi: 10.1016/j.ejvs.2020.12.015. Epub 2020 Dec 23.
6
Awareness and Perception of Thromboembolism and Thromboprophylaxis among Hospitalized Patients in Jordan.约旦住院患者对血栓栓塞症和血栓预防的认识。
Curr Clin Pharmacol. 2020;15(1):72-80. doi: 10.2174/1574884714666190823162055.
7
[Clinical features of patients with venous thromboembolism: 177 case analysis in 10 years].[静脉血栓栓塞症患者的临床特征:10年177例病例分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Apr;31(4):453-457. doi: 10.3760/cma.j.issn.2095-4352.2019.04.016.
8
Population-based study of risk of venous thromboembolism associated with various oral contraceptives.基于人群的与各种口服避孕药相关的静脉血栓栓塞风险研究。
Lancet. 1997 Jan 11;349(9045):83-8. doi: 10.1016/s0140-6736(96)07496-x.
9
Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.尽管进行了血栓预防,但住院患者静脉血栓栓塞的风险因素。
Thromb Res. 2014 Jan;133(1):25-9. doi: 10.1016/j.thromres.2013.09.011. Epub 2013 Sep 16.
10
Venous thromboembolism in an Asian COVID-19 cohort across 3 infection waves-a retrospective observational study.一项针对亚洲新冠病毒疾病(COVID-19)队列在三个感染波次中的静脉血栓栓塞症的回顾性观察研究。
Res Pract Thromb Haemost. 2023 Oct 11;7(7):102218. doi: 10.1016/j.rpth.2023.102218. eCollection 2023 Oct.

引用本文的文献

1
Effect of mild-to-moderate COVID‑19 on the incidence and risk factors for deep vein thrombosis in patients with hip fracture: a retrospective study.轻度至中度新型冠状病毒肺炎对髋部骨折患者深静脉血栓形成发生率及危险因素的影响:一项回顾性研究
BMC Surg. 2025 Mar 24;25(1):113. doi: 10.1186/s12893-025-02831-x.
2
Triple whammy in a patient with portal vein thrombosis.门静脉血栓形成患者的三重打击
Arch Clin Cases. 2024 May 14;11(1):16-18. doi: 10.22551/2024.42.1101.10280. eCollection 2024.
3
Estimated causal effects of common respiratory infections on cardiovascular risk: a meta-analysis.常见呼吸道感染对心血管风险的因果效应估计:荟萃分析。
Open Heart. 2023 Nov 28;10(2):e002501. doi: 10.1136/openhrt-2023-002501.
4
Post-acute sequelae of COVID-19 infection.新型冠状病毒感染的急性后遗症
Prev Med Rep. 2023 Feb;31:102097. doi: 10.1016/j.pmedr.2022.102097. Epub 2022 Dec 21.
5
Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients.蛋白质组学揭示了高危患者急性 COVID-19 期间的抗病毒宿主反应和 NETosis。
Biochim Biophys Acta Mol Basis Dis. 2023 Feb;1869(2):166592. doi: 10.1016/j.bbadis.2022.166592. Epub 2022 Nov 1.
6
Sports Imaging of COVID-19: A Multi-Organ System Review of Indications and Imaging Findings.COVID-19 的运动成像:多器官系统的适应证和影像学表现综述。
Sports Health. 2022 Sep-Oct;14(5):618-631. doi: 10.1177/19417381221106448. Epub 2022 Jun 23.
7
Ascending Aortic Thrombus After SARS-CoV-2 Infection.新型冠状病毒感染后升主动脉血栓形成
Cureus. 2022 Feb 22;14(2):e22496. doi: 10.7759/cureus.22496. eCollection 2022 Feb.

本文引用的文献

1
Arterial Thrombosis and Acute Limb Ischemia as a Complication of COVID-19 Infection.COVID-19 感染的并发症:动脉血栓形成和急性肢体缺血。
Am Surg. 2023 May;89(5):2046-2048. doi: 10.1177/00031348211023416. Epub 2021 May 28.
2
Cerebral venous thrombosis in a patient with mild COVID-19 infection.一名轻度新型冠状病毒肺炎感染患者的脑静脉血栓形成
Ann Acad Med Singap. 2021 Feb;50(2):188-190. doi: 10.47102/annals-acadmedsg.2020435.
3
Multiple Arterial Thrombosis in a COVID Patient With No Known Comorbidities With Mild Elevation of D-Dimer.一名无已知合并症且 D-二聚体轻度升高的 COVID 患者发生多发性动脉血栓形成。
Cureus. 2021 Feb 7;13(2):e13207. doi: 10.7759/cureus.13207.
4
COVID-19-Induced Mesenteric Thrombosis.新冠病毒感染所致肠系膜血栓形成
Cureus. 2021 Jan 28;13(1):e12953. doi: 10.7759/cureus.12953.
5
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.美国血液学会 2021 年关于 COVID-19 患者抗凝血栓预防治疗的指南。
Blood Adv. 2021 Feb 9;5(3):872-888. doi: 10.1182/bloodadvances.2020003763.
6
COVID-19 as the cause of thrombosis: recognising COVID-19 infection in apparently asymptomatic patients.COVID-19 导致的血栓:识别貌似无症状的 COVID-19 感染者。
BMJ Case Rep. 2021 Jan 7;14(1):e241027. doi: 10.1136/bcr-2020-241027.
7
Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization.一名新型冠状病毒肺炎患者在咽拭子检测转阴后发生致命性肺动脉血栓形成,该患者既往无症状。
Thromb J. 2021 Jan 6;19(1):1. doi: 10.1186/s12959-020-00255-6.
8
High prevalence of occult thrombosis in cases of mild/moderate COVID-19.轻度/中度 COVID-19 病例中隐匿性血栓形成的高患病率。
Int J Infect Dis. 2021 Mar;104:77-82. doi: 10.1016/j.ijid.2020.12.042. Epub 2020 Dec 19.
9
Bilateral Popliteal Vein Thrombosis, Acute Pulmonary Embolism and Mild COVID-19.双侧腘静脉血栓形成、急性肺栓塞与轻度新型冠状病毒肺炎
Cureus. 2020 Oct 28;12(10):e11213. doi: 10.7759/cureus.11213.
10
Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management.新型冠状病毒病相关血栓形成和凝血障碍:病理生理学特征综述及其对抗血栓治疗管理的影响。
J Am Heart Assoc. 2021 Feb 2;10(3):e019650. doi: 10.1161/JAHA.120.019650. Epub 2020 Nov 24.

轻度新冠病毒疾病作为静脉血栓栓塞的一个风险因素。

Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism.

作者信息

Clavijo María Manuela, Vicente Reparaz María de Los Angeles, Ruiz Juan I, Acuña María Angeles, Casali Claudia E, Aizpurua María Florencia, Mahuad Carolina V, Eciolaza Sebastian, Ventura Adriana, Garate Gonzalo M

机构信息

Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG.

Internal Medicine, Hospital Aleman, Buenos Aires, ARG.

出版信息

Cureus. 2021 Sep 24;13(9):e18236. doi: 10.7759/cureus.18236. eCollection 2021 Sep.

DOI:10.7759/cureus.18236
PMID:34722035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8544806/
Abstract

Introduction From the beginning of the current coronavirus disease 2019 (COVID-19) pandemic, there is cumulative evidence suggesting that patients hospitalized due to this disease are at a high risk for venous thromboembolism (VTE). The association between mild non-hospitalized illness and VTE is unclear. The purpose of this research is to assess the association between VTE and mild COVID-19 infection. Methods A case-control study was conducted. The cases were adult patients diagnosed with VTE from March 1, 2020 to March 31, 2021. The controls were randomly chosen adult patients who required healthcare services that were equivalent to those of the cases, for any cause, during the same time period, without a VTE diagnosis. To assess the association between mild COVID and VTE, a multivariate logistic regression analysis was conducted, considering other thromboembolic risk variables, such as age, gender and active cancer, among others. A p-value <0.05 was considered statistically significant. Results A total of 186 cases and 475 controls were analyzed. There were 21 (11.3%) and 31 (6.5%) patients infected with mild COVID-19 in the previous three months in the groups of cases and controls, respectively. Mild COVID-19 infection was statistically significant as a risk factor for VTE both in the univariate analysis and in the multivariate analysis, OR=1.82 (95% CI 1.02-3.26) and OR=2.62 (95% CI 1.34-5.13), respectively. Conclusion Mild COVID-19 infection might be an independent risk factor for VTE. We conclude that the results suggest some thromboprophylaxis strategy should be considered in certain patients with COVID-19 infection in an outpatient fashion.

摘要

引言 自2019年冠状病毒病(COVID-19)大流行开始以来,越来越多的证据表明,因该疾病住院的患者发生静脉血栓栓塞症(VTE)的风险很高。轻度非住院疾病与VTE之间的关联尚不清楚。本研究的目的是评估VTE与轻度COVID-19感染之间的关联。

方法 进行了一项病例对照研究。病例为2020年3月1日至2021年3月31日期间被诊断为VTE的成年患者。对照是在同一时期因任何原因需要与病例相同医疗服务且未被诊断为VTE的随机选择的成年患者。为了评估轻度COVID与VTE之间的关联,进行了多因素逻辑回归分析,同时考虑了其他血栓栓塞风险变量,如年龄、性别和活动性癌症等。p值<0.05被认为具有统计学意义。

结果 共分析了186例病例和475例对照。病例组和对照组中,在前三个月感染轻度COVID-19的患者分别有21例(11.3%)和31例(6.5%)。在单因素分析和多因素分析中,轻度COVID-19感染均作为VTE的危险因素具有统计学意义,OR分别为1.82(95%CI 1.02-3.26)和2.62(95%CI 1.34-5.13)。

结论 轻度COVID-19感染可能是VTE的独立危险因素。我们得出结论,结果表明对于某些COVID-19感染的门诊患者应考虑采取一些血栓预防策略。